Status:
COMPLETED
Prophylaxis to Reduce Postoperative Atrial Fibrillation in Cardiac Surgery
Lead Sponsor:
MaineHealth
Conditions:
Atrial Fibrillation
Atrial Flutter
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Atrial Fibrillation (AF) is a common postoperative complication of cardiac surgery, occuring in approximately 25-30% of coronary artery bypass graft (CABG) patients and 35-40% of heart valve repair/re...
Detailed Description
Atrial fibrillation is a common complication of cardiac surgery which is associated with increased morbidity, length of stay and cost. Efforts to mitigate this problem with beta blockers and amiodaron...
Eligibility Criteria
Inclusion
- adults (18 years of age or older)
- all comers for elective or urgent open heart surgery ( CABG, Valve repair or replacement, Combined CABG/Valves, CABG/other, Other)
Exclusion
- patients who refuse to participate
- patients with a history of atrial fibrillation or atrial flutter
- pediatric patients (under 18 years of age)
- Emergency surgery
- patients with contraindications to study medications
- patients with untreated thyroid disease, hepatic failure, pregnancy
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
304 Patients enrolled
Trial Details
Trial ID
NCT00953212
Start Date
August 1 2009
End Date
February 1 2012
Last Update
April 26 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maine Medical Center
Portland, Maine, United States, 04102